Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Dual function of ERH in primary miRNA biogenesis.

Nucleic acids research·2026
Same author

Bacterial infection reshapes monocyte and macrophage ontogeny at the CNS borders.

Science immunology·2026
Same author

Necroptosis triggers inflammatory interferon signatures in patient-derived metastatic breast cancer organoids.

Signal transduction and targeted therapy·2026
Same author

FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiation.

Journal of human immunity·2026
Same author

WORK-RELATED MUSCULOSKELETAL SYMPTOMS AMONG SONOGRAPHY PRACTITIONERS IN THE UAE: A CROSS-SECTIONAL STUDY.

Georgian medical news·2026
Same author

Comparative insights into the apoptosome, inflammasomes and PIDDosome.

Nature reviews. Immunology·2026

関連する実験動画

Updated: Jun 23, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.8K

The PIDDosome controls cardiomyocyte polyploidization during postnatal heart development

M Leone1, N Kinz2, F Eichin2

  • 1Biocenter, Institute for Developmental Immunology, Medical University of Innsbruck, Innsbruck, Austria. macileo@hotmail.com.

Cell death and differentiation
|January 12, 2026
PubMed
まとめ

The PIDDosome complex restricts polyploidy in heart cells during development. Loss of PIDDosome function increases cell ploidy, potentially impacting cardiac function in aged mice.

さらに関連する動画

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes
08:42

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes

Published on: August 28, 2016

28.2K
Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.6K

関連する実験動画

Last Updated: Jun 23, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.8K
Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes
08:42

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes

Published on: August 28, 2016

28.2K
Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.6K

科学分野:

  • 心臓病学
  • 細胞生物学
  • 発生生物学

背景:

  • 成体哺乳類の心筋細胞（CM）は、有糸分裂後であり、倍数性である。
  • CMの細胞周期終了と倍数性の理解は、心臓再生療法の鍵となる。

研究 の 目的:

  • 生後の心臓発生における心筋細胞（CM）の倍数性制御におけるPIDDosome複合体の役割を調査すること。
  • PIDDosomeを介した倍数性制御が心臓の構造と機能に与える影響を決定すること。

主な方法:

  • 心筋細胞の倍数性を評価するためのDNA含有量分析。
  • ANKRD26およびPIDD1を含むPIDDosome活性化メカニズムの調査。
  • 核内RNAシーケンシングおよび遺伝子欠損実験の利用。
  • PIDDosome活性が変化したマウスの心臓構造および機能の評価。

主要な成果:

  • 細胞固有のPIDDosome喪失は、心筋細胞の核および細胞の倍数性を増加させる。
  • PIDDosomeによって課される倍数性制御は、生後7日からP14日の間に行われる。
  • PIDDosomeの活性化にはANKRD26が必要であり、PIDD1を母中心体標的とする。
  • PIDDosome喪失による倍数性の増加は、高齢マウスの心機能に影響を与える。
  • PIDDosomeはp53に依存せずにCMの倍数化を制限するが、p21/Cdkn1aの誘導を必要とする。

結論:

  • PIDDosome複合体は、生後の心臓発生中に倍数性を制限するCM特異的な分化プログラムを実施する上で重要な役割を果たす。
  • CM倍数性のPIDDosomeを介した制御は、特に老化において心機能の維持に不可欠である。
  • これらの発見は、倍数性CMの増殖を制限することに関する新たな洞察を提供し、心臓再生療法の意味合いを持つ。